Apple v Samsung, and how to protect your business ideas: What’s on this week

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Apple v Samsung, and how to protect your business ideas: What’s on this week

Managing IP lists the IP decisions, conferences and events to watch out for this week

Monday, August 6

Apple v Samsung oral arguments, US District Court for the Northern District of California on Monday, Tuesday, and Friday

The Intellectual Property Office of the Philippines is holding a Patent Information Search Seminar Refresher Course II in Manila (continuing on Tuesday)

Thursday August 9

IP Australia and Clifton is offering a two-day course on trade marks database searching in Canberra

IP Australia is hosting a free lunchtime seminar, Protecting and Profiting From Your Business Ideas, in Melbourne

Saturday August 11

The Intellectual Property Office of the Philippines is hosting a class, Patent Drafting Training 1, location to be announced

more from across site and SHARED ros bottom lb

More from across our site

Via's Qi pool expands its footprint in Asia with the addition of Chinese smartphone giant and Japanese auto company
Matthew Cassie becomes the tenth partner to join the firm’s London outpost, and the second since it opened its new headquarters in May this year
A&O Shearman and Fish & Richardson invested in German talent, meanwhile, major firms have assembled for an on the merits case pitting KeeeX against OpenAI and Adobe
Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Gift this article